10x Genomics
TXG
$41.25
Share price
-0.10%
Change (1 day)
-2.71%
Change (1 year)
Categories
P/S ratio for 10x Genomics (TXG)
P/S ratio as of September 2023 (TTM): 8.53
According to 10x Genomics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.52942. At the end of 2023 the company had a P/S ratio of 11.4.
P/S ratio history for 10x Genomics from 2019 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 11.4 | 41.32% |
| 2022 | 8.08 | -76.19% |
| 2021 | 33.9 | -33.46% |
| 2020 | 51.0 | 70.84% |
| 2019 | 29.8 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | 25.3 | 196.30% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | 33.0 | 287.46% | 🇬🇧 UK |
 Novavax NVAX | 0.5037 | -94.09% | 🇺🇸 USA |
 Novocure
NVCR | 3.57 | -58.14% | Jersey |